Hyperparathyroidism: all 309 studies
Page 1 of 4. Open to participants first (23), then studies with results posted, then the rest; newest registration first within each.
- Parathyroidectomy After Kidney TransplantationRecruitingNCT07415421Not applicable
- Parathyroidectomy and Mobility StudyRecruitingNCT07103876
- Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)RecruitingNCT07083557
- Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)RecruitingNCT07010380
- Study of MT1013 Injection for the Treatment of Secondary Hyperparathyroidism (SHPT) Patients With Chronic Kidney Disease Undergoing Maintenance DialysisRecruitingNCT06976177Phase 2
- PET-TC in Thyroid EvaluationEnrolling by invitationNCT06852144
- Is Intraoperative PTH Monitoring Obsolete in Times of Choline PET/CT? a Prospective Multicenter Cohort Study to Determine Whether the Regular Preoperative Use of Choline-PET/CT Scan Obviate the Need for Intraoperative PTH-measurement in Patients with Primary HyperparathyreoidismNot yet recruitingNCT06804681
- Establishment of a Registry of Patients with Parathyroid DiseaseRecruitingNCT06797934
- Thermal Ablation Versus Parathyroidectomy for Secondary HyperparathyroidismNot yet recruitingNCT06709586
- Thermal Ablation Versus Parathyroidectomy for Primary HyperparathyroidismNot yet recruitingNCT06708871
- Diagnostic Performance of [11C]Choline PET/CT In the Preoperative Assessment of Primary HyperparathyroidismNot yet recruitingNCT06647966
- Intraoperative Parathyroid Hormone Monitoring to Guide Surgery in Renal hyperparathyroIdismNot yet recruitingNCT06542315Not applicable
- Genetic Bases of Neuroendocrine Neoplasms in Mexican PatientsRecruitingNCT06523582
- The Effect of Increasing Dialysate Calcium on T50 in Subjects With Secondary Hyperparathyroidism and ESKDNot yet recruitingNCT06398002Phase 2
- Quality of Life Change in Patients Undergoing Parathyroidectomy With End-stage Renal FailureNot yet recruitingNCT06378931
- Autofluorescence in Surgery for Primary HyperparathyroidismRecruitingNCT06230380Not applicable
- A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.RecruitingNCT06126016
- NUclear MEdicine DIagnostic and Artificial IntelligenceRecruitingNCT05963841
- Effects of Multiple Mega-dose of Vitamin D3 Supplementation on Ameliorating Moderate to Severe Chronic Pain in Hemodialysis PatientsRecruitingNCT05667090Not applicable
- The Bone-parathyroid Crosstalk in Primary HyperparathyroidismNot yet recruitingNCT05556499
- Natural History Study of Parathyroid DisordersRecruitingNCT04969926
- Total Parathyroidectomy With Autotransplantation Versus Total Parathyroidectomy Alone for Secondary HyperparathyroidismRecruitingNCT04922892Not applicable
- Calcitonin Pre-treatment to Improve SPECT-CT SensitivityRecruitingNCT03935984Phase 4
- Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT05152927Not applicableResults posted
- Evaluating Impact of NIRAF Detection for Identifying Parathyroid Glands During ParathyroidectomyCompletedNCT04299425Not applicableResults posted
- A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Paricalcitol For Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Participants With Stage 5 Chronic Kidney Disease (CKD)TerminatedNCT04064827Phase 3Results posted
- The Effect of Etelcalcetide on CKD-MBDCompletedNCT03960437Phase 2Results posted
- 18F-Fluorocholine for the Detection of Parathyroid AdenomasCompletedNCT03764007Phase 2/3Results posted
- Head-to-Head Study of Etelcalcetide and Cinacalcet in Asian Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT)CompletedNCT03299244Phase 3Results posted
- A Phase 1 Study to Evaluate PK, Safety and Tolerability of AMG 416CompletedNCT03283098Phase 1Results posted
- Phase 3 Study of KHK7580 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Primary HyperparathyroidismCompletedNCT03280264Phase 3Results posted
- Treatment of Primary Hyperparathyroidism With Denosumab and Cinacalcet.CompletedNCT03027557Phase 3Results posted
- A Single-dose Study in Paediatric Patients Aged 2 to Less Than 18 Years With Secondary Hyperparathyroidism (sHPT) Receiving HaemodialysisCompletedNCT02833857Phase 1Results posted
- Evaluating Alternative Medical Therapies in Primary HyperparathyroidismCompletedNCT02525796Phase 2/3Results posted
- Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on DialysisCompletedNCT02341417Phase 3Results posted
- Extension Study of CTAP101-CL-3001 or CTAP101-CL-3002CompletedNCT02282813Phase 3Results posted
- Study of the Efficacy of Local Analgesia as an Adjunct to General Anesthesia in Thyroidectomy and ParathyroidectomyCompletedNCT02205801Not applicableResults posted
- Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on DialysisTerminatedNCT02138838Phase 3Results posted
- Extension Study of Etelcalcetide for Treatment of Secondary Hyperparathyroidism in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT02102204Phase 3Results posted
- Pharmacokinetics and Excretion of [¹⁴C]Etelcalcetide (AMG 416) in Patients With End Stage Renal Disease (ESRD) Receiving DialysisCompletedNCT02054572Phase 1Results posted
- Efficacy and Safety of Paricalcitol in the Reduction of Secondary Hyperparathyroidism After Kidney Transplantation.CompletedNCT01939977Phase 4Results posted
- Study to Assess the Impact on Calcium Levels When Hemodialysis Patients With Secondary Hyperparathyroidism (SHPT) Switch From Cinacalcet to EtelcalcetideCompletedNCT01932970Phase 3Results posted
- Head-to-Head Study of Etelcalcetide (AMG 416) and CinacalcetCompletedNCT01896232Phase 3Results posted
- Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01788046Phase 3Results posted
- Extension Study of Etelcalcetide in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on HemodialysisCompletedNCT01785875Phase 3Results posted
- Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease on HemodialysisCompletedNCT01785849Phase 3Results posted
- Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. ParicalcitolTerminatedNCT01725113Phase 4Results posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01704079Phase 3Results posted
- The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC StudyCompletedNCT01691781Not applicableResults posted
- Safety and Efficacy of CTAP101 to Treat Secondary Hyperparathyroidism in Stage 3 or 4 CKD and Vitamin D InsufficiencyCompletedNCT01651000Phase 3Results posted
- Efficacy and Safety of Ultrasonic Ablation to Treat Secondary Hyperparathyroidism in Chronic Kidney Disease PatientsCompletedNCT01640184Not applicableResults posted
- Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary HyperparathyroidismTerminatedNCT01576146Phase 2Results posted
- Denosumab in Primary HyperparathyroidismTerminatedNCT01558115Phase 4Results posted
- A Pilot Clinical Study Evaluating the Effect of Parathyroid Hormone (PTH) Lowering On Erythropoietin Consumption in Calcitriol-Resistant PatientsCompletedNCT01506947Phase 4Results posted
- Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary HyperparathyroidismTerminatedNCT01439867Phase 2Results posted
- Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone DisorderCompletedNCT01414114Phase 2Results posted
- Observational Program of Zemplar in Patients With End Stage Chronic Kidney Disease and Parathyroid Disorder on Hemodialysis in the Russian FederationCompletedNCT01401478Results posted
- A Study to Evaluate the Safety of Paricalcitol Capsules in Pediatric Subjects Ages 10 to 16 With Stage 5 Chronic Kidney Disease Receiving Peritoneal Dialysis or HemodialysisCompletedNCT01382212Phase 3Results posted
- Quality of Life in Greek Hemodialysis Patients Receiving Zemplar IntravenousCompletedNCT01368042Results posted
- Comparison of Efficacy and Safety of Paricalcitol Injection With Maxacalcitol Injection in Adult Japanese Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary HyperparathyroidismCompletedNCT01341782Phase 3Results posted
- Vitamin D Repletion in Primary HyperparathyroidismCompletedNCT01306656Phase 4Results posted
- Study to Evaluate Cinacalcet in Children With Chronic Kidney DiseaseCompletedNCT01290029Phase 1Results posted
- Pediatric Chronic Kidney Disease Safety and EfficacyTerminatedNCT01277510Phase 3Results posted
- Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid GlandsCompletedNCT01273597Results posted
- Study to Assess Patient Management Practices and Quality of Life With Paricalcitol Capsules in the Treatment of Secondary Hyperparathyroidism in Stage 3-5 Chronic Kidney Disease Patients Not Yet on DialysisCompletedNCT01265992Results posted
- Safety, Tolerability and Efficacy of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT01254565Phase 2Results posted
- Evaluation of Treatment With Zemplar Capsules in the Therapy of Secondary Hyperparathyroidism (SHPT)CompletedNCT01224782Results posted
- Safety/Efficacy Study of CTAP101 in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism (SHPT)CompletedNCT01219855Phase 2/3Results posted
- Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedNCT01191762Phase 3Results posted
- Compare the Efficacy of Cinacalcet vs Traditional Vitamin D for Secondary Hyperparathyroidism (SHPT) Among Subjects Undergoing HemodialysisCompletedNCT01181531Phase 4Results posted
- Trial Of Paricalcitol and Cholecalciferol(Vitamin D3) in the Treatment Of Secondary Hyperparathyroidism in Patients After ROUX-EN-Y Gastric Bypass SurgeryCompletedNCT01138475Phase 3Results posted
- Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Hemodialysis Patients With Secondary HyperparathyroidismCompletedNCT01134562Phase 1Results posted
- Safety, Tolerability and Pharmacokinetics of Etelcalcetide in Healthy Male VolunteersCompletedNCT01134549Phase 1Results posted
- Study to Evaluate Safety of Vitamin D Receptor Activators in Patients Ages 0 to 16 With Chronic Kidney Disease Stage 5 Receiving Peritoneal Dialysis Within Current Clinical PracticeTerminatedNCT01134315Results posted
- Trial to Optimize Mineral Outcomes in Dialysis PatientsCompletedNCT01100723Phase 4Results posted
- Long-Term Therapy Outcomes When Treating Chronic Kidney Disease (CKD) Patients With Paricalcitol in German and Austrian Clinical PracticeCompletedNCT01083849Results posted
- Paricalcitol Oral Therapy in Predialysis CKD Patients. The Greek ExperienceCompletedNCT01083186Results posted
- Follow-up Patients With End Stage Renal Disease Receiving Zemplar to Prevent and Treat Secondary HyperparathyroidismCompletedNCT01081665Results posted
- Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 YearsCompletedNCT01073462Results posted
- Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney DiseaseTerminatedNCT01012414Phase 3Results posted
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseCompletedNCT00999037Not applicableResults posted
- Paricalcitol Compared to Maxacalcitol in Chronic Kidney Disease Patients With Secondary HyperparathyroidismCompletedNCT00990704Phase 2Results posted
- Evaluation of the Effectiveness of Paricalcitol Versus Cinacalcet With Low-Dose Vitamin DCompletedNCT00977080Phase 4Results posted
- Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant RecipientsCompletedNCT00975000Phase 3Results posted
- PRIMARA: A Prospective Descriptive Observational Study to Review Mimpara (Cinacalcet) Use in Patients With Primary Hyperparathyroidism in Clinical PracticeCompletedNCT00928408Results posted
- Effectiveness and Safety of IV Zemplar in Patients on Hemodialysis and With Secondary Hyperparathyroidism Using iPTH/100 as Initial DoseCompletedNCT00891813Phase 4Results posted
- Maintenance Vitamin D Therapy for Secondary Hyperparathyroidism (2HPT)CompletedNCT00828347Not applicableResults posted
- Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT)CompletedNCT00823303Phase 4Results posted
- 20070360 Incident DialysisCompletedNCT00803712Phase 4Results posted
- Suspected Deficient Activation of Vitamin D in Patients With Secondary HyperparathyroidismCompletedNCT00754442Not applicableResults posted
- Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Patients With Hemodialysis (HD)CompletedNCT00701805Phase 2Results posted
- Effect of Vitamin D Treatment in Primary HyperparathyroidismCompletedNCT00674154Phase 2/3Results posted
- Dose-response Study of Paricalcitol Injection in Chronic Kidney Disease Patients Receiving HemodialysisCompletedNCT00667576Phase 2Results posted
- Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis SubjectsTerminatedNCT00664430Phase 4Results posted
- Mineral Metabolism and Vascular Effects of Vitamin D Therapy in Kidney Transplant PatientsTerminatedNCT00646282Phase 4Results posted
- Oral Paricalcitol in Kidney Transplant RecipientsCompletedNCT00587158Not applicableResults posted
- One Week Parathyroid Hormone-related Protein (PTHrP) IV Dose Escalation StudyCompletedNCT00580788Early Phase 1Results posted
- Efficacy and Safety of 6 Months Treatment With Paricalcitol Injection or Oral in Patients With Secondary Hyperparathyroidism on DialysisCompletedNCT00537979Phase 4Results posted
- How Vitamin D Analogues Affect Endothelial Cells in Patients on DialysisCompletedNCT00528788Phase 4Results posted
- A Study of Cinacalcet to Improve Achievement of National Kidney Foundation Kidney Disease Outcomes Quality Initiative (K/DOQI) Targets in Patients With End Stage Renal Disease (ESRD)CompletedNCT00431496Phase 4Results posted